How’s this for a loyalty record: About 85% of the partners and associates at Knobbe Martens Olson & Bear LLP have never worked as lawyers for any other firm. And, since its inception in 1962, no lawyers have ever left the IP specialty firm as a group.
Japanese drug maker Astellas Pharma Inc. has filed a patent infringement lawsuit against India’s Ranbaxy Laboratories over its plans to make a generic version of the prostate drug Flomax.
In an increasingly globalized economy, Morrison & Foerster LLP’s worldwide presence helps the general-practice firm fight patent disputes simultaneously on three continents.
Cephalon has dropped its patent infringement suit against Swiss drug maker Sandoz following that drugmaker's decision not to market a generic version of Cephalon's drug Provigil.
German drug maker Altana AG and U.S. marketing partner Wyeth have filed a lawsuit to block India's Sun Pharmaceutical Industries Ltd. from selling a generic version of the ulcer treatment Protonix.
The U.S. Food and Drug Administration has granted Barr Laboratories a final approval for a generic version of Aventis Pharmaceuticals' blockbuster allergy medicine Allegra-D, the company said.
The U.S. Court of Appeals for the Federal Circuit has dismissed Canadian generics maker Apotex Inc.’s lawsuit against Pfizer, Inc. after Pfizer covenanted not to sue Apotex for infringement of a patent for the hypertension drug Accupril.
Canadian chip maker Mosaid Technologies Inc. has filed another patent lawsuit against German rival Infineon Technologies AG in a Texas federal court, just days after facing a major setback in a separate lawsuit against the same company in New Jersey.
In a stinging blow to Canadian chip maker Mosaid Technologies Inc., a federal judge in New Jersey has ruled against six of seven of its claims in its patent infringement lawsuit against German rival Infineon Technologies Inc.
A federal court in New Jersey has granted summary judgment of non-infringement of one patent in generic maker Barr Pharmaceuticals Inc.'s patent challenge against Sanofi-Aventis’ Allegra allergy drug, Barr said.
Indian drug maker Ranbaxy Laboratories Ltd. and Israeli partner Teva Pharmaceuticals have vowed to file an immediate appeal of a New Jersey federal court’s preliminary injunction against sales of a generic version of Pfizer’s hypertension drug Accupril.
Pfizer, Inc. has won a preliminary injunction halting sales of a generic version of the hypertension drug Accupril, marketed by Israeli generics maker Teva Pharmaceuticals and Indian drug maker Ranbaxy Pharmaceuticals.
Bausch & Lomb has withdrawn its patent infringement lawsuit filed last week against Inverness Medical Innovations Inc., which the eye care maker said was based on erroneous information.
Eye care company Bausch & Lomb Inc. has sued yet another rival over patents for a dietary supplement designed to combat eye disease.
Pfizer Inc. has sued India’s Ranbaxy and Israel’s Teva Pharmaceuticals in New Jersey federal court, alleging that the two companies are infringing a process patent for the hypertension drug Accupril.
Teva Pharmaceutical and GlaxoSmithKline have settled their patent litigation over Glaxo’s Lamictal with a deal under which Teva will be allowed to launch an exclusive generic version later this year.
AT&T has changed the name of its Internet phone service to resolve a trademark infringement dispute with its competitor Vonage, according to Vonage.
Brown Raysman has hired the former head of Coudert Brothers’ intellectual property department for its Los Angeles office.
Northeastern law firm McCarter & English has hired two intellectual property attorneys for its office in Newark, New Jersey from Wolff & Samson PC.
Bolstered by a slew of new pharmaceutical clients, Brown Raysman Millstein Felder & Steiner LLP has seen the revenues from its intellectual property practice nearly double in the past 18 months.